PCV84 Resource Utilization and Costs for Candesartan in Heart Failure- Assessment of Reduction in Mortality and Morbidity (CHARM) Programme for the Austrian Setting
Nov 1, 2011, 00:00
10.1016/j.jval.2011.08.804
https://www.valueinhealthjournal.com/article/S1098-3015(11)02366-7/fulltext
Title :
PCV84 Resource Utilization and Costs for Candesartan in Heart Failure- Assessment of Reduction in Mortality and Morbidity (CHARM) Programme for the Austrian Setting
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(11)02366-7&doi=10.1016/j.jval.2011.08.804
First page :
A379
Section Title :
Cardiovascular Disorders
Open access? :
No
Section Order :
771